Consolidated Statement of Changes in Redeemable Noncontrolling Interest and Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Total Stockholders’ Equity	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Redeemable Noncontrolling Interest
Outstanding shares, beginning balance (in shares) at Jul. 31, 2023			957,344,162
Stockholders' equity, beginning balance at Jul. 31, 2023		$ 5,987,440	$ 96	$ 938,910	$ (141,006)	$ 5,189,440	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		332,527				332,527	5
Currency translation adjustment		(36,353)			(36,353)
Acquisition of noncontrolling interest (in shares)			2,499,993
Acquisition of noncontrolling interest		112,075		112,075			25,217
Exercise of stock options, net of repurchased shares (in shares)			331,358
Exercise of stock options, net of repurchased shares		7,412		8,123		(711)
Stock-based compensation (in shares)			32,761
Stock-based compensation		8,316		8,316
Outstanding shares, ending balance (in shares) at Oct. 31, 2023			960,208,274
Stockholders' equity, ending balance at Oct. 31, 2023		6,411,417	$ 96	1,067,424	(177,359)	5,521,256	25,222
Outstanding shares, beginning balance (in shares) at Jul. 31, 2023			957,344,162
Stockholders' equity, beginning balance at Jul. 31, 2023		5,987,440	$ 96	938,910	(141,006)	5,189,440	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)	$ 1,040,169
Currency translation adjustment	(15,801)
Outstanding shares, ending balance (in shares) at Apr. 30, 2024			962,268,657
Stockholders' equity, ending balance at Apr. 30, 2024		7,171,253	$ 96	1,102,684	(156,807)	6,225,280	24,933
Outstanding shares, beginning balance (in shares) at Oct. 31, 2023			960,208,274
Stockholders' equity, beginning balance at Oct. 31, 2023		6,411,417	$ 96	1,067,424	(177,359)	5,521,256	25,222
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		325,635				325,635	(108)
Currency translation adjustment		32,080			32,080
Exercise of stock options, net of repurchased shares (in shares)			828,799
Exercise of stock options, net of repurchased shares		3,906		5,359		(1,453)
Stock-based compensation (in shares)			119,004
Stock-based compensation		8,601		8,601
Shares issued for Employee Stock Purchase Plan (in shares)			155,419
Shares issued for Employee Stock Purchase Plan		5,961		5,961
Outstanding shares, ending balance (in shares) at Jan. 31, 2024			961,311,496
Stockholders' equity, ending balance at Jan. 31, 2024		6,787,600	$ 96	1,087,345	(145,279)	5,845,438	25,114
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)	382,110	382,291				382,291	(181)
Currency translation adjustment	$ (11,528)	(11,528)			(11,528)
Exercise of stock options, net of repurchased shares (in shares)			872,081
Exercise of stock options, net of repurchased shares		4,446		6,895		(2,449)
Stock-based compensation (in shares)			85,183
Stock-based compensation		8,448		8,448
Shares issued (redeemed) for Employee Stock Purchase Plan (in shares)			(103)
Shares issued (redeemed) for Employee Stock Purchase Plan		(4)		(4)
Outstanding shares, ending balance (in shares) at Apr. 30, 2024			962,268,657
Stockholders' equity, ending balance at Apr. 30, 2024		7,171,253	$ 96	1,102,684	(156,807)	6,225,280	24,933
Outstanding shares, beginning balance (in shares) at Jul. 31, 2024	962,967,011		962,967,011
Stockholders' equity, beginning balance at Jul. 31, 2024	$ 7,524,011	7,524,011	$ 96	1,120,985	(142,972)	6,545,902	24,544
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		362,086				362,086	(910)
Currency translation adjustment		(1,767)			(1,767)
Exercise of stock options, net of repurchased shares (in shares)			476,491
Exercise of stock options, net of repurchased shares		2,137		2,857		(720)
Stock-based compensation (in shares)			80,900
Stock-based compensation		9,845		9,845
Outstanding shares, ending balance (in shares) at Oct. 31, 2024			963,524,402
Stockholders' equity, ending balance at Oct. 31, 2024		7,896,312	$ 96	1,133,687	(144,739)	6,907,268	23,634
Outstanding shares, beginning balance (in shares) at Jul. 31, 2024	962,967,011		962,967,011
Stockholders' equity, beginning balance at Jul. 31, 2024	$ 7,524,011	7,524,011	$ 96	1,120,985	(142,972)	6,545,902	24,544
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)	1,153,055
Currency translation adjustment	$ 29,672
Outstanding shares, ending balance (in shares) at Apr. 30, 2025	966,812,661		966,812,661
Stockholders' equity, ending balance at Apr. 30, 2025	$ 8,781,193	8,781,193	$ 97	1,195,757	(113,300)	7,698,639	21,504
Outstanding shares, beginning balance (in shares) at Oct. 31, 2024			963,524,402
Stockholders' equity, beginning balance at Oct. 31, 2024		7,896,312	$ 96	1,133,687	(144,739)	6,907,268	23,634
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		387,400				387,400	(859)
Currency translation adjustment		(26,821)			(26,821)
Exercise of stock options, net of repurchased shares (in shares)			2,296,400
Exercise of stock options, net of repurchased shares		28,213	$ 1	29,976		(1,764)
Stock-based compensation (in shares)			69,085
Stock-based compensation		8,749		8,749
Shares issued for Employee Stock Purchase Plan (in shares)			163,279
Shares issued for Employee Stock Purchase Plan		7,404		7,404
Outstanding shares, ending balance (in shares) at Jan. 31, 2025			966,053,166
Stockholders' equity, ending balance at Jan. 31, 2025		8,301,257	$ 97	1,179,816	(171,560)	7,292,904	22,775
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)	405,338	406,609				406,609	(1,271)
Currency translation adjustment	$ 58,260	58,260			58,260
Exercise of stock options, net of repurchased shares (in shares)			726,815
Exercise of stock options, net of repurchased shares		6,464		7,338		(874)
Stock-based compensation (in shares)			32,680
Stock-based compensation		8,603		8,603
Outstanding shares, ending balance (in shares) at Apr. 30, 2025	966,812,661		966,812,661
Stockholders' equity, ending balance at Apr. 30, 2025	$ 8,781,193	$ 8,781,193	$ 97	$ 1,195,757	$ (113,300)	$ 7,698,639	$ 21,504